MG-D 1809

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameMG-D 1809
Drug Alias NameMG-D-1809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsKidney NeoplasmsThyroid NeoplasmsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetagone Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetagone Biotech Inc
Inactive CompaniesN/A
Active IndicationsKidney NeoplasmsThyroid NeoplasmsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A